[89Zr]Zr-huJ591 immuno-PET targeting PSMA in IDH mutant anaplastic oligodendroglioma

[⁸⁹Zr]Zr-huJ591 immuno-PET targeting PSMA in IDH mutant anaplastic oligodendroglioma

Eur J Nucl Med Mol Imaging. 2022 Jan;49(2):783-785. doi: 10.1007/s00259-021-05543-5. Epub 2021 Sep 8.

Simone Krebs^{1

2}, Christian Grommes³, Michael R McDevitt^{1

2}, Sean D Carlin⁴, Joseph A O'Donoghue⁵, Maya S Graham³, Robert J Young⁶, Heiko Schöder^{1

2}, Philip H Gutin⁷, Neil H Bander⁸, Joseph R Osborne^{9

10}

¹ Department of Radiology, Molecular Imaging and Therapy Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
² Department of Radiology, Weill Cornell Medical College, New York, NY, USA.
³ Department of Neurology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
⁴ Division of Nuclear Medicine Imaging and Therapy, Department of Radiology, University of Pennsylvania, Philadelphia, PA, USA.
⁵ Department of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
⁶ Department of Radiology, Neuroradiology Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
⁷ Department of Neurosurgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
⁸ Department of Urology, Weill Cornell Medicine, New York, NY, USA.
⁹ Department of Radiology, Weill Cornell Medical College, New York, NY, USA. [email protected].
¹⁰ Molecular Imaging and Therapeutics, Weill Cornell Medical College, 525 E 68th St, New York, NY, 10065, USA. [email protected].

No abstract available